Fennec Pharma former director Rosty Raykov disposes of 9,599 common shares for $99,926.59
Share
Listen to the news
Fennec Pharma former director Rosty Raykov disposes of 9,599 common shares for $99,926.59
  • Fennec Pharmaceuticals: former director Rosty Raykov reported option exercise activity dated July 1, 2026.
  • Exercised stock options for 15,597 common shares at USD 2.45.
  • Sold 9,599 common shares at USD 10.41, flagged as tax-related selling tied to the option exercise.
  • Beneficial ownership in common shares rose to 138,855 following the transactions.
  • Derivative position showed 1.53 million stock options beneficially owned following the reported transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468316-26-000017), on July 02, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending